A detailed history of Operose Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Operose Advisors LLC holds 101 shares of AMGN stock, worth $28,569. This represents 0.01% of its overall portfolio holdings.

Number of Shares
101
Previous 77 31.17%
Holding current value
$28,569
Previous $24,000 33.33%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$309.38 - $337.38 $7,425 - $8,097
24 Added 31.17%
101 $32,000
Q4 2023

Feb 12, 2024

SELL
$255.7 - $288.46 $19,688 - $22,211
-77 Reduced 50.0%
77 $22,000
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $16,180 - $20,088
74 Added 92.5%
154 $41,000
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $17,956 - $20,252
80 New
80 $18,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $151B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Operose Advisors LLC Portfolio

Follow Operose Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Operose Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Operose Advisors LLC with notifications on news.